CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey - New Study Released

Boston, MA -- (SBWire) -- 08/11/2014 --GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Turkey. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure.

Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

View Full Report Details and Table of Contents

Turkey's population stood at approximately 76.7 million in 2013, having grown at a Compound Annual Growth Rate (CAGR) of 1.4%, from 2008. The implementation of the Health Transformation Program (Saglikta Donus, um Programi, HTP) resulted in social security reforms that were aimed at improving the universal health coverage. The available infrastructure for healthcare industries and the high number of healthcare institutions makes Turkey an attractive location for the manufacture and marketing of pharmaceutical products.

The government is trying to increase pharmaceutical R&D in Turkey, and in 2012, it introduced a new investment incentives program that had four basic schemes to increase foreign investment. The pharmaceutical market was worth approximately $12.5 billion, in 2012, and was the sixth-largest pharmaceutical market in Europe. It is set to grow at a CAGR of 7.3% from 2008 to reach $21.5 billion in 2020. The medical device market was valued at approximately $1.9 billion in 2008 and is estimated to grow at a CAGR of 4.7% to reach an estimated $3.3 billion in 2020. These positive growth trends can be primarily attributed to -

- An increasing elderly population
- Universal health coverage
- Government initiatives

Scope:

The report provides information on the healthcare, regulatory, and reimbursement landscape in Turkey, and includes:

- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

- Profiles and SWOT analyses of the major players in the pharmaceutical market: Abdi Ibrahim, Novartis, Sanofi, Bilim and Pfizer; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, F. Hoffmann-La Roche, Essilor International, GE healthcare, and Fresenius Medical Care

- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure

- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to Get This Report:

This report will enhance your decision-making capability by allowing you to:

- Develop business strategies by understanding the trends shaping and driving Turkey's healthcare market

- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Turkey's healthcare market in the future

- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors

- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships

- Identify, understand, and capitalize on the opportunities and challenges in Turkey's healthcare market

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 800-844-8156

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines